Amplia Therapeutics Limited Share Price
Stocks
ATX
AU0000023822
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1200 AUD | +9.09% |
|
+9.09% | -20.00% |
| 29/05 | Amplia Therapeutics Limited Reports Earnings Results for the Full Year Ended March 31, 2026 | CI |
| 29/05 | Amplia Therapeutics Limited Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 6.16Cr 4.33Cr 3.77Cr 3.48Cr 3.27Cr 6.12Cr 407.88Cr 41Cr 16Cr 201.01Cr 16Cr 16Cr 696.69Cr | P/E 2027 * |
-5.22x | P/E 2028 * | -20x |
|---|---|---|---|---|---|
| Enterprise Value | 4.61Cr 3.24Cr 2.82Cr 2.6Cr 2.45Cr 4.58Cr 305.24Cr 31Cr 12Cr 150.43Cr 12Cr 12Cr 521.38Cr | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 4.01x |
| Free-Float |
84.81% | Yield 2027 * |
-
| Yield 2028 * | - |
| 1 day | +9.09% | ||
| 1 week | +9.09% | ||
| Current month | -11.11% | ||
| 1 month | -20.00% | ||
| 3 months | +6.67% | ||
| Current year | -20.00% |
| 1 week | 0.1 |  | 0.12 |
| 1 month | 0.1 | | 0.15 |
| Current year | 0.1 | | 0.28 |
| 1 year | 0.1 | | 0.42 |
| 3 years | 0.05 | | 0.42 |
| 5 years | 0.05 | | 0.42 |
| 10 years | 0.04 | | 18.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 05/12/2022 | |
Hamish George
DFI | Director of Finance/CFO | - | 01/10/2021 |
Jason Lickliter
CTO | Chief Tech/Sci/R&D Officer | - | 12/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Peach
BRD | Director/Board Member | 70 | 02/09/2015 |
Warwick Tong
CHM | Chairman | - | 25/05/2018 |
Jane Bell
BRD | Director/Board Member | - | 12/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 08/25/08 | Buy | Founder | 86,957 | 0.0224% | ||
| 08/25/08 | Buy | Director | 6,52,174 | 0.1681% | ||
| 08/25/08 | Fiscal year | Chairman | 7,50,000 | 0.1933% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.09% | +9.09% | +57.89% | +48.15% | 3.99Cr | |
| -2.23% | -0.03% | +61.34% | +109.10% | 5.62TCr | |
| +4.60% | +5.85% | +54.47% | +43.04% | 4.38TCr | |
| -1.44% | +1.51% | -12.94% | -17.33% | 2.33TCr | |
| -2.69% | -0.95% | -3.68% | +374.02% | 2.13TCr | |
| +3.22% | +3.77% | +19.92% | -35.05% | 1.58TCr | |
| -0.67% | +1.18% | +12.91% | -39.22% | 1.56TCr | |
| -1.01% | -2.97% | +27.42% | +174.08% | 1.32TCr | |
| +3.07% | +3.59% | +25.54% | - | 1.2TCr | |
| +4.95% | +7.51% | +123.21% | +249.05% | 1.19TCr | |
| Average | +1.69% | +3.38% | +36.61% | +100.65% | 2.13TCr | |
| Weighted average by Cap. | +0.51% | +3.54% | +38.01% | +97.89% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 1Cr 70.26L 61.22L 56.43L 53.08L 99.3L 66Cr 6.71Cr 2.61Cr 33Cr 2.64Cr 2.58Cr 113.1Cr |
| Net income | -1.16Cr -81.5L -71.01L -65.46L -61.57L -1.15Cr -77Cr -7.79Cr -3.02Cr -38Cr -3.06Cr -2.99Cr -131.2Cr | -36L -25.29L -22.04L -20.32L -19.11L -35.75L -24Cr -2.42Cr -93.87L -12Cr -94.94L -92.9L -41Cr |
| Net Debt | -1.55Cr -1.09Cr -94.89L -87.47L -82.27L -1.54Cr -102.64Cr -10Cr -4.04Cr -51Cr -4.09Cr -4Cr -175.31Cr | -2.15Cr -1.51Cr -1.32Cr -1.21Cr -1.14Cr -2.13Cr -142.37Cr -14Cr -5.61Cr -70Cr -5.67Cr -5.55Cr -243.17Cr |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | 0.1200 $ | +9.09% | 18,27,022 |
| 17/26/17 | 0.1100 $ | +4.76% | 2,94,142 |
| 16/26/16 | 0.1050 $ | -4.55% | 14,30,872 |
| 15/26/15 | 0.1100 $ | 0.00% | 4,93,143 |
| 12/26/12 | 0.1100 $ | 0.00% | 9,70,140 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1200AUD
Average target price
0.4200AUD
Spread / Average Target
+250.00%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATX Stock
Select your edition
All financial news and data tailored to specific country editions
